KLBF.JK
PT Kalbe Farma Tbk.$700.00
-1.41%Jun 19, 2026
Market cap
$31.67T
52w range
—
P / E
—
EPS · FY 2025
$80.51
Volume
—
Revenue · FY 2025
$35.32T
+8.27% YoY
Explain this page
Arphra AIPlain-English read on PT Kalbe Farma Tbk.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,620.32
— vs spot
Recommendation
n/a
4 of 4 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →KLBF.JK
700.00-51.05%H 1,595L 630.00MA50 851.90MA200 1,089Avg vol 74.1M
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $9.68T | $1.03T | $22.74 |
| Q4 Dec 2025 | $9.34T | $1.03T | $22.71 |
| Q3 Sep 2025 | $8.91T | $656.41B | $14.49 |
| Q2 Jun 2025 | $8.23T | $898.17B | $19.78 |
| Q1 Mar 2025 | $8.85T | $1.08T | $23.57 |
| Q4 Dec 2024 | $8.39T | $862.26B | $18.84 |
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Peers
No peer list available for KLBF.JK.
Total assets
$30.7T
Total debt
$297.28B
Cash & equiv
$4.33T
Operating CF
$3.27T
Free cash flow
$2.46T
Buybacks
-$842.09B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $35.32T | $4.55T | $3.66T | $80.51 | +10.38% |
| FY 2024 | $32.63T | $4.07T | $3.24T | $70.16 | +9.93% |
| FY 2023 | $30.45T | $3.63T | $2.77T | $59.81 | +9.09% |
| FY 2022 | $28.93T | $4.49T | $3.38T | $72.71 | +11.69% |
| FY 2021 | $26.26T | $4.16T | $3.18T | $67.92 | +12.12% |